{
    "data": [
        {
            "conversation_id": "745454184342818816",
            "created_at": "2016-06-22T03:11:42.000Z",
            "id": "745454184342818816",
            "lang": "en",
            "public_metrics": {
                "like_count": 0,
                "quote_count": 0,
                "reply_count": 0,
                "retweet_count": 0
            },
            "text": "@EU_Commission: Iran's NA must not be copyrighted;for the torture came from them. Three in mind. I was one of yours.\n\n@bdawired"
        },
        {
            "conversation_id": "745438909316759552",
            "created_at": "2016-06-22T02:11:00.000Z",
            "id": "745438909316759552",
            "lang": "en",
            "public_metrics": {
                "like_count": 0,
                "quote_count": 0,
                "reply_count": 0,
                "retweet_count": 0
            },
            "text": "@EU_Commission It is Capitalism which always maintains the umbrella. EU must stay within it's referendum with UK to the Right for some.\n\n@bd"
        },
        {
            "conversation_id": "745432928742608897",
            "created_at": "2016-06-22T01:47:14.000Z",
            "id": "745432928742608897",
            "lang": "en",
            "public_metrics": {
                "like_count": 0,
                "quote_count": 0,
                "reply_count": 0,
                "retweet_count": 0
            },
            "text": "@EU_Commission I have land and assets in The United States The President is after, an sexual harassment. \n\n@IranPrimer"
        },
        {
            "conversation_id": "745428689240743936",
            "created_at": "2016-06-22T01:30:23.000Z",
            "id": "745428689240743936",
            "lang": "en",
            "public_metrics": {
                "like_count": 0,
                "quote_count": 0,
                "reply_count": 0,
                "retweet_count": 1
            },
            "text": "@EU_Commission My Identification file is with a man in Las Vegas as Zand-Alaee Fereydoun who ordered a death sentence.\n\nPrime"
        },
        {
            "conversation_id": "745415431423393792",
            "created_at": "2016-06-22T00:37:42.000Z",
            "id": "745415431423393792",
            "lang": "en",
            "public_metrics": {
                "like_count": 0,
                "quote_count": 0,
                "reply_count": 0,
                "retweet_count": 0
            },
            "text": "@EU_Commission we know you fucking hate england but if we leave just let scotland back in please we did nothing wrong"
        },
        {
            "conversation_id": "745404418829389828",
            "created_at": "2016-06-21T23:53:57.000Z",
            "id": "745404418829389828",
            "lang": "en",
            "public_metrics": {
                "like_count": 0,
                "quote_count": 0,
                "reply_count": 0,
                "retweet_count": 0
            },
            "text": "@EU_Commission I want to report Julia Lim for thinking she's rich enough to be my friend. Who does she think she is??"
        },
        {
            "conversation_id": "745373316899278848",
            "created_at": "2016-06-21T21:50:21.000Z",
            "id": "745373316899278848",
            "lang": "en",
            "public_metrics": {
                "like_count": 0,
                "quote_count": 0,
                "reply_count": 0,
                "retweet_count": 0
            },
            "text": "@EU_Commission @JunckerEU Why haven't the EU been taking a bigger part in our referendum debate? #EUref #EUreferendum"
        },
        {
            "conversation_id": "745371592943771648",
            "created_at": "2016-06-21T21:43:30.000Z",
            "id": "745371592943771648",
            "lang": "en",
            "public_metrics": {
                "like_count": 0,
                "quote_count": 0,
                "reply_count": 0,
                "retweet_count": 0
            },
            "text": "@EU_Commission When there is sexual intimacy involved quantized he must be removed from the seat as President. \n\n@BermudaBat"
        },
        {
            "conversation_id": "743722233625874432",
            "created_at": "2016-06-21T21:41:20.000Z",
            "id": "745371046811938816",
            "lang": "qam",
            "public_metrics": {
                "like_count": 0,
                "quote_count": 0,
                "reply_count": 0,
                "retweet_count": 0
            },
            "text": "@EU_Commission @Bulc_EU @jyrkikatainen @Transport_EU @inea_eu @jakubadamEU"
        },
        {
            "conversation_id": "745367268985495553",
            "created_at": "2016-06-21T21:26:19.000Z",
            "id": "745367268985495553",
            "lang": "en",
            "public_metrics": {
                "like_count": 0,
                "quote_count": 0,
                "reply_count": 0,
                "retweet_count": 0
            },
            "text": "@EU_Commission I am as Ashram a prisoner of war in The United States because of OBAMA. Close his banks in Suisse. \n\nAshram"
        },
        {
            "conversation_id": "745345052990377984",
            "created_at": "2016-06-21T19:58:03.000Z",
            "id": "745345052990377984",
            "lang": "en",
            "public_metrics": {
                "like_count": 0,
                "quote_count": 0,
                "reply_count": 0,
                "retweet_count": 0
            },
            "text": "@EU_Commission @eureferendum #VoteLeave #keepbritian terrible human discussion came to this but ..... Get the hell out"
        },
        {
            "conversation_id": "745340908476981248",
            "created_at": "2016-06-21T19:41:35.000Z",
            "id": "745340908476981248",
            "lang": "en",
            "public_metrics": {
                "like_count": 0,
                "quote_count": 0,
                "reply_count": 0,
                "retweet_count": 0
            },
            "text": "@EU_Commission Stuff the EU"
        },
        {
            "conversation_id": "745140024618803200",
            "created_at": "2016-06-21T19:02:32.000Z",
            "id": "745331085400285188",
            "lang": "en",
            "public_metrics": {
                "like_count": 0,
                "quote_count": 0,
                "reply_count": 0,
                "retweet_count": 0
            },
            "text": "@EU_Commission @bertrandpiccard @MarosSefcovic @solarimpulse Photon Electric Plane:Seeds for self-drive,flying cars w/ 3D Photon Neuron Code"
        },
        {
            "conversation_id": "745214711369629696",
            "created_at": "2016-06-21T17:41:35.000Z",
            "id": "745310711228829696",
            "lang": "en",
            "public_metrics": {
                "like_count": 0,
                "quote_count": 0,
                "reply_count": 0,
                "retweet_count": 0
            },
            "text": "@EU_Commission and so has non EU Israel."
        },
        {
            "conversation_id": "745303487584546816",
            "created_at": "2016-06-21T17:12:53.000Z",
            "id": "745303487584546816",
            "lang": "en",
            "public_metrics": {
                "like_count": 0,
                "quote_count": 0,
                "reply_count": 0,
                "retweet_count": 0
            },
            "text": "@EU_Commission understand your reluctance to be involved in domestic politics,but you are coming across as you don't care if UK leaves."
        },
        {
            "conversation_id": "745268923986149376",
            "created_at": "2016-06-21T14:55:32.000Z",
            "id": "745268923986149376",
            "lang": "en",
            "public_metrics": {
                "like_count": 0,
                "quote_count": 0,
                "reply_count": 0,
                "retweet_count": 0
            },
            "text": "@EU_Commission Poor EU-steelproducers. Again, China produced more steel last month. Month after month. #ArcelorMittal"
        },
        {
            "conversation_id": "745265592819720192",
            "created_at": "2016-06-21T14:42:18.000Z",
            "id": "745265592819720192",
            "lang": "es",
            "public_metrics": {
                "like_count": 0,
                "quote_count": 0,
                "reply_count": 0,
                "retweet_count": 1
            },
            "text": "@EU_Commission DIRECTIVA 2009/28/CE (62) Los costes de conexi\u00f3n [...] procedentes [...] deben [...]\ny no discriminatorios #RenovablesSOS"
        },
        {
            "conversation_id": "745257665102766080",
            "created_at": "2016-06-21T14:10:48.000Z",
            "id": "745257665102766080",
            "lang": "de",
            "public_metrics": {
                "like_count": 0,
                "quote_count": 0,
                "reply_count": 0,
                "retweet_count": 0
            },
            "text": "@EU_Commission mit ihren Sanktionen gegen Russland arbeiten Volkswirtschaften souver\u00e4ner Staaten zu zerst\u00f6ren #merkel @BPJoachimGauck @zdf"
        },
        {
            "conversation_id": "745256419855863808",
            "created_at": "2016-06-21T14:05:51.000Z",
            "id": "745256419855863808",
            "lang": "fr",
            "public_metrics": {
                "like_count": 0,
                "quote_count": 0,
                "reply_count": 0,
                "retweet_count": 0
            },
            "text": "@EU_Commission avec ses sanctions contre la Russie travaillent \u00e0 d\u00e9molir les \u00e9conomies des pays souverains @fhollande  @Stop_The_EU"
        },
        {
            "conversation_id": "745256037951934464",
            "created_at": "2016-06-21T14:04:20.000Z",
            "id": "745256037951934464",
            "lang": "en",
            "public_metrics": {
                "like_count": 0,
                "quote_count": 0,
                "reply_count": 0,
                "retweet_count": 0
            },
            "text": "@EU_Commission with its sanctions against Russia working to demolish economies of sovereign countries\n@MinPres @JunckerEU @eucopresident"
        },
        {
            "conversation_id": "745245866475159552",
            "created_at": "2016-06-21T13:23:55.000Z",
            "id": "745245866475159552",
            "lang": "ro",
            "public_metrics": {
                "like_count": 0,
                "quote_count": 0,
                "reply_count": 0,
                "retweet_count": 0
            },
            "text": "@EU_Commission: UE a adoptat o serie de m\u0103suri destinate combaterii evaziunii fiscale a companiilor multina\u021bionale (Agerpres) #evaziune"
        },
        {
            "conversation_id": "745245822166568960",
            "created_at": "2016-06-21T13:23:44.000Z",
            "id": "745245822166568960",
            "lang": "ro",
            "public_metrics": {
                "like_count": 0,
                "quote_count": 0,
                "reply_count": 0,
                "retweet_count": 0
            },
            "text": "@EU_Commission: UE a adoptat o serie de m\u0103suri destinate combaterii evaziunii fiscale a companiilor multina\u021bionale (Agerpres) #evaziune"
        },
        {
            "conversation_id": "745222355371188227",
            "created_at": "2016-06-21T12:16:47.000Z",
            "id": "745228970963116032",
            "lang": "en",
            "public_metrics": {
                "like_count": 0,
                "quote_count": 0,
                "reply_count": 0,
                "retweet_count": 0
            },
            "text": "@EU_Commission propping up failing states costs billions of \u20ac as well. The unelected on the EU gravy train."
        },
        {
            "conversation_id": "745221653853016066",
            "created_at": "2016-06-21T11:47:42.000Z",
            "id": "745221653853016066",
            "lang": "en",
            "public_metrics": {
                "like_count": 0,
                "quote_count": 0,
                "reply_count": 0,
                "retweet_count": 0
            },
            "text": "@EU_Commission we just want same thing as #Brexit. Referendum for #Biafra. #Selfdetermination. @EmekaGift"
        },
        {
            "conversation_id": "745213760843898880",
            "created_at": "2016-06-21T11:46:05.000Z",
            "id": "745221245839499264",
            "lang": "en",
            "public_metrics": {
                "like_count": 0,
                "quote_count": 0,
                "reply_count": 0,
                "retweet_count": 0
            },
            "text": "@EU_Commission @JunckerEU Sheer junk-genius.  Get out, public robber and mafiosi."
        },
        {
            "conversation_id": "745213760843898880",
            "created_at": "2016-06-21T11:27:25.000Z",
            "id": "745216549598953472",
            "lang": "en",
            "public_metrics": {
                "like_count": 0,
                "quote_count": 0,
                "reply_count": 0,
                "retweet_count": 0
            },
            "text": "@EU_Commission @JunckerEU EU children deprived from education? What will EU do without them? @manuelvalls @fhollande @ThierryMARIANI"
        },
        {
            "conversation_id": "745213760843898880",
            "created_at": "2016-06-21T11:25:08.000Z",
            "id": "745215975360962560",
            "lang": "en",
            "public_metrics": {
                "like_count": 0,
                "quote_count": 0,
                "reply_count": 0,
                "retweet_count": 0
            },
            "text": "@EU_Commission @JunckerEU If they accept and fulfill their obligations, yes"
        },
        {
            "conversation_id": "745213760843898880",
            "created_at": "2016-06-21T11:23:28.000Z",
            "id": "745215556979044356",
            "lang": "fr",
            "public_metrics": {
                "like_count": 0,
                "quote_count": 0,
                "reply_count": 0,
                "retweet_count": 0
            },
            "text": "@EU_Commission @JunckerEU bone chance La Grece"
        },
        {
            "conversation_id": "745215183241490432",
            "created_at": "2016-06-21T11:21:59.000Z",
            "id": "745215183241490432",
            "lang": "en",
            "public_metrics": {
                "like_count": 0,
                "quote_count": 0,
                "reply_count": 0,
                "retweet_count": 0
            },
            "text": "@EU_Commission college to discuss #Brexit during tomorrow's weekly meeting"
        },
        {
            "conversation_id": "745213760843898880",
            "created_at": "2016-06-21T11:18:46.000Z",
            "id": "745214374336401408",
            "lang": "de",
            "public_metrics": {
                "like_count": 1,
                "quote_count": 0,
                "reply_count": 0,
                "retweet_count": 1
            },
            "text": "@EU_Commission @JunckerEU na dann mal Prost \ud83c\udf77\ud83c\udf7a\ud83c\udf7b"
        },
        {
            "conversation_id": "745213760843898880",
            "created_at": "2016-06-21T11:18:39.000Z",
            "id": "745214343374077953",
            "lang": "fr",
            "public_metrics": {
                "like_count": 0,
                "quote_count": 0,
                "reply_count": 0,
                "retweet_count": 0
            },
            "text": "@EU_Commission @JunckerEU n'importe quoi"
        },
        {
            "conversation_id": "745185808580116480",
            "created_at": "2016-06-21T10:19:45.000Z",
            "id": "745199519797751808",
            "lang": "en",
            "public_metrics": {
                "like_count": 0,
                "quote_count": 0,
                "reply_count": 0,
                "retweet_count": 0
            },
            "text": "@EU_Commission \n\u00a3350m may not be the magic number when it comes to how much the #UK gives to the #EuropeanUnion each week #EURealityCheck"
        },
        {
            "conversation_id": "745185808580116480",
            "created_at": "2016-06-21T09:37:44.000Z",
            "id": "745188946896883716",
            "lang": "en",
            "public_metrics": {
                "like_count": 0,
                "quote_count": 0,
                "reply_count": 0,
                "retweet_count": 0
            },
            "text": "@EU_Commission @pierremoscovici @VDombrovskis @EU_Taxud Costs who billions of Euro? Tax avoidance is legal."
        },
        {
            "conversation_id": "744809480903237635",
            "created_at": "2016-06-21T09:33:13.000Z",
            "id": "745187809099649024",
            "lang": "en",
            "public_metrics": {
                "like_count": 0,
                "quote_count": 0,
                "reply_count": 0,
                "retweet_count": 1
            },
            "text": "@EU_Commission the key question is what skills will be needed for what purpose. Reshaping organizations &amp; social systems for a better world"
        },
        {
            "conversation_id": "745185808580116480",
            "created_at": "2016-06-21T09:32:03.000Z",
            "id": "745187515334795264",
            "lang": "en",
            "public_metrics": {
                "like_count": 0,
                "quote_count": 0,
                "reply_count": 0,
                "retweet_count": 0
            },
            "text": "@EU_Commission When did your budget last balance ?"
        },
        {
            "conversation_id": "745176458520199169",
            "created_at": "2016-06-21T08:48:07.000Z",
            "id": "745176458520199169",
            "lang": "en",
            "public_metrics": {
                "like_count": 2,
                "quote_count": 0,
                "reply_count": 0,
                "retweet_count": 1
            },
            "text": "@EU_Commission #CarlosMoedas stresses the idea of the innovation council is not to creat an insistitution @digfestEU @SusChem #innovation"
        },
        {
            "conversation_id": "745165538855256065",
            "created_at": "2016-06-21T08:04:43.000Z",
            "id": "745165538855256065",
            "lang": "en",
            "public_metrics": {
                "like_count": 2,
                "quote_count": 0,
                "reply_count": 0,
                "retweet_count": 1
            },
            "text": "@EU_Commission launched a series of factsheets \"Farm economy focus by sector\"   #horticulture, #wine, #fruit, #olives, #cereals #EU_FADN"
        },
        {
            "conversation_id": "745150751316418561",
            "created_at": "2016-06-21T07:23:01.000Z",
            "id": "745155043863650304",
            "lang": "en",
            "public_metrics": {
                "like_count": 0,
                "quote_count": 0,
                "reply_count": 2,
                "retweet_count": 0
            },
            "text": "@EU_Commission   \n@Esther_de_Lange  \n@J_DijsseIbIoem  \n@PieterOmtzigt  \ngood iniative. but eu /eugoverments must not be to greedy !"
        },
        {
            "conversation_id": "745135610373898241",
            "created_at": "2016-06-21T06:05:48.000Z",
            "id": "745135610373898241",
            "lang": "en",
            "public_metrics": {
                "like_count": 0,
                "quote_count": 0,
                "reply_count": 0,
                "retweet_count": 0
            },
            "text": "@EU_Commission the European union is the very definition of what is wrong with the world. Down to it's propaganda and corporatist attitude."
        },
        {
            "conversation_id": "745052730457231361",
            "created_at": "2016-06-21T00:36:28.000Z",
            "id": "745052730457231361",
            "lang": "en",
            "public_metrics": {
                "like_count": 0,
                "quote_count": 0,
                "reply_count": 0,
                "retweet_count": 0
            },
            "text": "@EU_Commission Give us #Biafra or expect #40millions of immigrant in #Europe soon."
        },
        {
            "conversation_id": "745022169223208960",
            "created_at": "2016-06-20T22:35:01.000Z",
            "id": "745022169223208960",
            "lang": "en",
            "public_metrics": {
                "like_count": 0,
                "quote_count": 0,
                "reply_count": 1,
                "retweet_count": 0
            },
            "text": "@EU_Commission any update on the  Vnuk ruling.Will it effect motorsport in the way it's suggested.Will it close race tracks. @brianhayesMEP"
        },
        {
            "conversation_id": "744817044806217729",
            "created_at": "2016-06-20T22:00:22.000Z",
            "id": "745013448405311489",
            "lang": "en",
            "public_metrics": {
                "like_count": 0,
                "quote_count": 0,
                "reply_count": 0,
                "retweet_count": 0
            },
            "text": "@EU_Commission @TimmermansEU @FedericaMog @eu_echo @europeaid @eu_eeas @EUHomeAffairs please consider the appeal of @MSF for #safepassage"
        },
        {
            "conversation_id": "744972011454201856",
            "created_at": "2016-06-20T19:15:43.000Z",
            "id": "744972011454201856",
            "lang": "en",
            "public_metrics": {
                "like_count": 0,
                "quote_count": 0,
                "reply_count": 0,
                "retweet_count": 0
            },
            "text": "@EU_Commission  likelihood of a democratically elected EU parliament? currently @vote_leave based on undemocratic EU but willing to listen"
        },
        {
            "conversation_id": "744967708429680640",
            "created_at": "2016-06-20T18:58:37.000Z",
            "id": "744967708429680640",
            "lang": "en",
            "public_metrics": {
                "like_count": 0,
                "quote_count": 0,
                "reply_count": 0,
                "retweet_count": 0
            },
            "text": "@EU_Commission @EU_Commission Britain Retreat ex EU; wisdom \u201cStop acting so small. You are the universe in ecstatic motion.\u201d Rumi"
        },
        {
            "conversation_id": "744945815450333188",
            "created_at": "2016-06-20T17:31:37.000Z",
            "id": "744945815450333188",
            "lang": "en",
            "public_metrics": {
                "like_count": 0,
                "quote_count": 0,
                "reply_count": 0,
                "retweet_count": 0
            },
            "text": "@EU_Commission if brexit is chosen then European Finance cannot stay in London !"
        },
        {
            "conversation_id": "744940156621291520",
            "created_at": "2016-06-20T17:09:08.000Z",
            "id": "744940156621291520",
            "lang": "en",
            "public_metrics": {
                "like_count": 0,
                "quote_count": 0,
                "reply_count": 0,
                "retweet_count": 0
            },
            "text": "@EU_Commission\nNATIONS  THE VENEZUELAN TYRANT  DONT OPEN THE HUMANITARIAN DUCT NO FOOD NO MEDICINES THIS IS  CRIME AGAINST HUMANITY RT"
        },
        {
            "conversation_id": "744907044227026944",
            "created_at": "2016-06-20T14:57:33.000Z",
            "id": "744907044227026944",
            "lang": "fr",
            "public_metrics": {
                "like_count": 1,
                "quote_count": 0,
                "reply_count": 0,
                "retweet_count": 1
            },
            "text": "@EU_Commission : dette des entreprises plafonn\u00e9e \u00e0 30% des revenus, mais dette publique espagnole filant \u00e0 97% PIB ; o\u00f9 est la coh\u00e9rence ?"
        },
        {
            "conversation_id": "744897308597305344",
            "created_at": "2016-06-20T14:18:52.000Z",
            "id": "744897308597305344",
            "lang": "en",
            "public_metrics": {
                "like_count": 1,
                "quote_count": 0,
                "reply_count": 0,
                "retweet_count": 0
            },
            "text": "@EU_Commission Bedlington @eupatientsforum we must continue multi-stakeholder approach on biosimilars at EU level"
        },
        {
            "conversation_id": "744896242963062784",
            "created_at": "2016-06-20T14:14:38.000Z",
            "id": "744896242963062784",
            "lang": "en",
            "public_metrics": {
                "like_count": 0,
                "quote_count": 0,
                "reply_count": 0,
                "retweet_count": 0
            },
            "text": "@EU_Commission Bedlington @eupatientsforum there are still fundamental differences of opinion on biosimilars switching"
        },
        {
            "conversation_id": "744895536617119744",
            "created_at": "2016-06-20T14:11:50.000Z",
            "id": "744895536617119744",
            "lang": "en",
            "public_metrics": {
                "like_count": 0,
                "quote_count": 0,
                "reply_count": 0,
                "retweet_count": 0
            },
            "text": "@EU_Commission Bedlington @eupatientsforum studies from Hungary, UK are collecting real world evidence on biosimilars including on switching"
        },
        {
            "conversation_id": "744895281314009088",
            "created_at": "2016-06-20T14:10:49.000Z",
            "id": "744895281314009088",
            "lang": "en",
            "public_metrics": {
                "like_count": 0,
                "quote_count": 0,
                "reply_count": 0,
                "retweet_count": 0
            },
            "text": "@EU_Commission Nicola Bedlington @eupatientsforum availability of biosimilars can expand access to treatments for diseases and ease budgets"
        },
        {
            "conversation_id": "744890727629471744",
            "created_at": "2016-06-20T13:52:43.000Z",
            "id": "744890727629471744",
            "lang": "en",
            "public_metrics": {
                "like_count": 0,
                "quote_count": 0,
                "reply_count": 0,
                "retweet_count": 0
            },
            "text": "@EU_Commission invests \u20ac 6,7 bln in #infrastructure. @Min_IenM will use 118 mln for #airtrafficmanagement &amp; #EVinfrastructure. @NLintheUSA."
        },
        {
            "conversation_id": "744887240472530944",
            "created_at": "2016-06-20T13:38:52.000Z",
            "id": "744887240472530944",
            "lang": "en",
            "public_metrics": {
                "like_count": 0,
                "quote_count": 0,
                "reply_count": 0,
                "retweet_count": 0
            },
            "text": "@EU_Commission Emma Woodford Hibou Consulting: Some 20 patient organisation consulted in new biosimilar Q&amp;A 2016"
        },
        {
            "conversation_id": "744884916169678848",
            "created_at": "2016-06-20T13:29:37.000Z",
            "id": "744884916169678848",
            "lang": "en",
            "public_metrics": {
                "like_count": 0,
                "quote_count": 0,
                "reply_count": 0,
                "retweet_count": 1
            },
            "text": "@EU_Commission Wiek @eular_org we need lay summaries of recommendations on biosimilars, relevant studies, trials, reviews"
        },
        {
            "conversation_id": "744884730626215936",
            "created_at": "2016-06-20T13:28:53.000Z",
            "id": "744884730626215936",
            "lang": "en",
            "public_metrics": {
                "like_count": 0,
                "quote_count": 0,
                "reply_count": 0,
                "retweet_count": 0
            },
            "text": "@EU_Commission Wiek @eular_org in some west European countries patients switched to biosimilars on cost grounds; shared decision lacking"
        },
        {
            "conversation_id": "744884251447926784",
            "created_at": "2016-06-20T13:26:59.000Z",
            "id": "744884251447926784",
            "lang": "en",
            "public_metrics": {
                "like_count": 0,
                "quote_count": 0,
                "reply_count": 0,
                "retweet_count": 0
            },
            "text": "@EU_Commission Wiek @eular_org we desire data collection for at least a couple of years to see what happens in switches to biosimilars"
        },
        {
            "conversation_id": "744884036330459136",
            "created_at": "2016-06-20T13:26:08.000Z",
            "id": "744884036330459136",
            "lang": "en",
            "public_metrics": {
                "like_count": 0,
                "quote_count": 0,
                "reply_count": 0,
                "retweet_count": 0
            },
            "text": "@EU_Commission Wiek @eular_org National registries for biosimilars should be embedded in an international network"
        },
        {
            "conversation_id": "744883817308131328",
            "created_at": "2016-06-20T13:25:15.000Z",
            "id": "744883817308131328",
            "lang": "en",
            "public_metrics": {
                "like_count": 0,
                "quote_count": 0,
                "reply_count": 0,
                "retweet_count": 0
            },
            "text": "@EU_Commission Wiek @eular_org for clear identification and traceability, brand name, not INN should be used"
        },
        {
            "conversation_id": "744883644670578688",
            "created_at": "2016-06-20T13:24:34.000Z",
            "id": "744883644670578688",
            "lang": "en",
            "public_metrics": {
                "like_count": 0,
                "quote_count": 0,
                "reply_count": 0,
                "retweet_count": 0
            },
            "text": "@EU_Commission Wiek @eular_org Patients critique transferability of data from one rheumatic disease to others w/o additional studies"
        },
        {
            "conversation_id": "744883104637132800",
            "created_at": "2016-06-20T13:22:26.000Z",
            "id": "744883104637132800",
            "lang": "en",
            "public_metrics": {
                "like_count": 0,
                "quote_count": 0,
                "reply_count": 0,
                "retweet_count": 0
            },
            "text": "@EU_Commission Dieter Wiek @eular_org the safety of biosimilars is paramount for patients and patient organisations"
        },
        {
            "conversation_id": "744882927557820416",
            "created_at": "2016-06-20T13:21:43.000Z",
            "id": "744882927557820416",
            "lang": "en",
            "public_metrics": {
                "like_count": 0,
                "quote_count": 0,
                "reply_count": 0,
                "retweet_count": 0
            },
            "text": "@EU_Commission Dieter Wiek @eular_org we welcome new treatment options, but biosimilars have raised a number of questions and concerns"
        },
        {
            "conversation_id": "744882658187018241",
            "created_at": "2016-06-20T13:20:39.000Z",
            "id": "744882658187018241",
            "lang": "en",
            "public_metrics": {
                "like_count": 0,
                "quote_count": 0,
                "reply_count": 0,
                "retweet_count": 0
            },
            "text": "@EU_Commission Dieter Wiek @eular_org patient should be informed about their therapy options, the efficacy, risks and side-effects"
        },
        {
            "conversation_id": "744881826888581120",
            "created_at": "2016-06-20T13:17:21.000Z",
            "id": "744881826888581120",
            "lang": "en",
            "public_metrics": {
                "like_count": 0,
                "quote_count": 0,
                "reply_count": 0,
                "retweet_count": 1
            },
            "text": "@EU_Commission Dieter Wiek @eular_org biosimilars offer more treatment options to physicians and wider access to patients; great choice"
        },
        {
            "conversation_id": "744879521191583744",
            "created_at": "2016-06-20T13:08:11.000Z",
            "id": "744879521191583744",
            "lang": "en",
            "public_metrics": {
                "like_count": 1,
                "quote_count": 0,
                "reply_count": 1,
                "retweet_count": 3
            },
            "text": "@EU_Commission Frank J\u00f8rgensen @EAHPtweet Hospital pharmacists across Europe are about to become more and more visible"
        },
        {
            "conversation_id": "744878442383020032",
            "created_at": "2016-06-20T13:03:54.000Z",
            "id": "744878442383020032",
            "lang": "en",
            "public_metrics": {
                "like_count": 1,
                "quote_count": 0,
                "reply_count": 0,
                "retweet_count": 2
            },
            "text": "@EU_Commission Wilkinson @PGEU community pharmacists can facilitate safe, rational, cost-effective, timely access to biologics/biosimilars"
        },
        {
            "conversation_id": "744877040353034240",
            "created_at": "2016-06-20T12:58:20.000Z",
            "id": "744877040353034240",
            "lang": "en",
            "public_metrics": {
                "like_count": 1,
                "quote_count": 0,
                "reply_count": 0,
                "retweet_count": 1
            },
            "text": "@EU_Commission Jamie Wilkinson @PGEU increasingly, pharmacists across Europe have started services for patients starting new meds"
        },
        {
            "conversation_id": "744876855459717120",
            "created_at": "2016-06-20T12:57:36.000Z",
            "id": "744876855459717120",
            "lang": "en",
            "public_metrics": {
                "like_count": 1,
                "quote_count": 0,
                "reply_count": 0,
                "retweet_count": 1
            },
            "text": "@EU_Commission Jamie Wilkinson @PGEU whether it \u2018s a biosimilar or biological, pharmacists still need to provide information, advice"
        },
        {
            "conversation_id": "744876474105204736",
            "created_at": "2016-06-20T12:56:05.000Z",
            "id": "744876474105204736",
            "lang": "en",
            "public_metrics": {
                "like_count": 2,
                "quote_count": 0,
                "reply_count": 0,
                "retweet_count": 1
            },
            "text": "@EU_Commission Jamie Wilkinson @PGEU  a pharmacy/pharmacist can be accessed within 30 mins for 98% of the European population"
        },
        {
            "conversation_id": "744874536496144384",
            "created_at": "2016-06-20T12:48:23.000Z",
            "id": "744874536496144384",
            "lang": "en",
            "public_metrics": {
                "like_count": 0,
                "quote_count": 0,
                "reply_count": 0,
                "retweet_count": 0
            },
            "text": "@EU_Commission Westhovens KBVR-SRBR Biosimilars: need for info and education will not be enough. Beliefs and perception must be addressed"
        },
        {
            "conversation_id": "744874272603144192",
            "created_at": "2016-06-20T12:47:20.000Z",
            "id": "744874272603144192",
            "lang": "en",
            "public_metrics": {
                "like_count": 0,
                "quote_count": 0,
                "reply_count": 0,
                "retweet_count": 0
            },
            "text": "@EU_Commission Ren\u00e9 Westhovens KBVR-SRBR there are means of achieving savings other than changing drug, ie. responsible prescribing"
        },
        {
            "conversation_id": "744817044806217729",
            "created_at": "2016-06-20T12:44:24.000Z",
            "id": "744873534774718464",
            "lang": "en",
            "public_metrics": {
                "like_count": 2,
                "quote_count": 0,
                "reply_count": 0,
                "retweet_count": 0
            },
            "text": "@EU_Commission I guess you're not afraid of making ridiculously hypocritical statements... #EnoughWithPropoganda"
        },
        {
            "conversation_id": "744873379497402368",
            "created_at": "2016-06-20T12:43:47.000Z",
            "id": "744873379497402368",
            "lang": "en",
            "public_metrics": {
                "like_count": 0,
                "quote_count": 0,
                "reply_count": 0,
                "retweet_count": 0
            },
            "text": "@EU_Commission Ren\u00e9 Westhovens KBVR-SRBR: 2013 survey: Only 22% physicians considered themselves as very familiar with biosimilars"
        },
        {
            "conversation_id": "744872170690576384",
            "created_at": "2016-06-20T12:38:59.000Z",
            "id": "744872170690576384",
            "lang": "en",
            "public_metrics": {
                "like_count": 1,
                "quote_count": 1,
                "reply_count": 0,
                "retweet_count": 2
            },
            "text": "@EU_Commission Salvatore Leone @efcca if a patient feels good with a biologic, we should not take the chance of switching to a biosimilar"
        },
        {
            "conversation_id": "744871008885215232",
            "created_at": "2016-06-20T12:34:22.000Z",
            "id": "744871008885215232",
            "lang": "en",
            "public_metrics": {
                "like_count": 1,
                "quote_count": 0,
                "reply_count": 0,
                "retweet_count": 1
            },
            "text": "@EU_Commission Salvatore Leone @efcca sharing decisions leads to patient centric-care"
        },
        {
            "conversation_id": "744870852970307584",
            "created_at": "2016-06-20T12:33:45.000Z",
            "id": "744870852970307584",
            "lang": "en",
            "public_metrics": {
                "like_count": 1,
                "quote_count": 0,
                "reply_count": 0,
                "retweet_count": 1
            },
            "text": "@EU_Commission Salvatore Leone @efcca patient/physician cooperation id crucial to achieve co-owned results, improve communication"
        },
        {
            "conversation_id": "744869123428089856",
            "created_at": "2016-06-20T12:26:52.000Z",
            "id": "744869123428089856",
            "lang": "en",
            "public_metrics": {
                "like_count": 0,
                "quote_count": 0,
                "reply_count": 0,
                "retweet_count": 0
            },
            "text": "@EU_Commission Vulto @ErasmusMC: Lack of knowledge base among prescribers/patients largest reason why biosimilars are not being used enough"
        },
        {
            "conversation_id": "744868746599219200",
            "created_at": "2016-06-20T12:25:22.000Z",
            "id": "744868746599219200",
            "lang": "en",
            "public_metrics": {
                "like_count": 0,
                "quote_count": 0,
                "reply_count": 0,
                "retweet_count": 0
            },
            "text": "@EU_Commission Prof Arnold Vulto @ErasmusMC: medicines agencies should emit a clear message on biosimilars"
        },
        {
            "conversation_id": "744868593507143680",
            "created_at": "2016-06-20T12:24:46.000Z",
            "id": "744868593507143680",
            "lang": "en",
            "public_metrics": {
                "like_count": 0,
                "quote_count": 0,
                "reply_count": 0,
                "retweet_count": 0
            },
            "text": "@EU_Commission Prof Arnold Vulto @ErasmusMC: we need to build trust on biosimilars; reduce the information gap"
        },
        {
            "conversation_id": "744868345309200384",
            "created_at": "2016-06-20T12:23:47.000Z",
            "id": "744868345309200384",
            "lang": "en",
            "public_metrics": {
                "like_count": 0,
                "quote_count": 0,
                "reply_count": 0,
                "retweet_count": 0
            },
            "text": "@EU_Commission Prof Arnold Vulto @ErasmusMC: MEB if a patient is treated with a biosimilar, brand name and batch name must be recorded"
        },
        {
            "conversation_id": "744868019067830272",
            "created_at": "2016-06-20T12:22:29.000Z",
            "id": "744868019067830272",
            "lang": "en",
            "public_metrics": {
                "like_count": 0,
                "quote_count": 0,
                "reply_count": 0,
                "retweet_count": 0
            },
            "text": "@EU_Commission Prof Arnold Vulto @ErasmusMC: 12 biosimilars in EMA licensing pipline"
        },
        {
            "conversation_id": "744867869486387200",
            "created_at": "2016-06-20T12:21:53.000Z",
            "id": "744867869486387200",
            "lang": "en",
            "public_metrics": {
                "like_count": 0,
                "quote_count": 0,
                "reply_count": 0,
                "retweet_count": 0
            },
            "text": "@EU_Commission Prof Arnold Vulto @ErasmusMC: we have a unified licencing system for biosimilars, but not unified access"
        },
        {
            "conversation_id": "744867691861794816",
            "created_at": "2016-06-20T12:21:11.000Z",
            "id": "744867691861794816",
            "lang": "en",
            "public_metrics": {
                "like_count": 0,
                "quote_count": 0,
                "reply_count": 0,
                "retweet_count": 0
            },
            "text": "@EU_Commission Prof Arnold Vulto @ErasmusMC: the savings potential of biosimilars is underused"
        },
        {
            "conversation_id": "744867531329048580",
            "created_at": "2016-06-20T12:20:33.000Z",
            "id": "744867531329048580",
            "lang": "en",
            "public_metrics": {
                "like_count": 0,
                "quote_count": 0,
                "reply_count": 0,
                "retweet_count": 0
            },
            "text": "@EU_Commission Prof Arnold Vulto @ErasmusMC  local situations are affecting the uptake of biosimilars across Europe"
        },
        {
            "conversation_id": "744822868165332992",
            "created_at": "2016-06-20T12:16:38.000Z",
            "id": "744866548905566208",
            "lang": "en",
            "public_metrics": {
                "like_count": 0,
                "quote_count": 0,
                "reply_count": 0,
                "retweet_count": 0
            },
            "text": "@EU_Commission @EU_ScienceHub @TNavracsicsEU what about democracy? Unelected on the EU gravy train."
        },
        {
            "conversation_id": "744848007980425216",
            "created_at": "2016-06-20T11:02:58.000Z",
            "id": "744848007980425216",
            "lang": "en",
            "public_metrics": {
                "like_count": 0,
                "quote_count": 0,
                "reply_count": 0,
                "retweet_count": 0
            },
            "text": "@EU_Commission K Gecse Semmelweis Uni: Ecco survey 2015 19.5% prescribers have little/no confidence in biosimilars compared with 63% in 2013"
        },
        {
            "conversation_id": "744770524455313408",
            "created_at": "2016-06-20T10:53:07.000Z",
            "id": "744845529234841600",
            "lang": "en",
            "public_metrics": {
                "like_count": 0,
                "quote_count": 0,
                "reply_count": 0,
                "retweet_count": 0
            },
            "text": "@EU_Commission hmm not that worried about Brexit then!"
        },
        {
            "conversation_id": "743380873374892033",
            "created_at": "2016-06-20T10:42:52.000Z",
            "id": "744842951919022080",
            "lang": "en",
            "public_metrics": {
                "like_count": 0,
                "quote_count": 0,
                "reply_count": 0,
                "retweet_count": 0
            },
            "text": "@EU_Commission @JunckerEU talk to who you like mate .. U.S. Brits are leaving your stinking, sinking empire"
        },
        {
            "conversation_id": "744839966954426372",
            "created_at": "2016-06-20T10:31:01.000Z",
            "id": "744839966954426372",
            "lang": "en",
            "public_metrics": {
                "like_count": 0,
                "quote_count": 0,
                "reply_count": 0,
                "retweet_count": 0
            },
            "text": "@EU_Commission Fraser Cummings @UHSFT: nurse prescribing is important in biologics, but must be balanced with decision making"
        },
        {
            "conversation_id": "744839218216656896",
            "created_at": "2016-06-20T10:28:02.000Z",
            "id": "744839218216656896",
            "lang": "en",
            "public_metrics": {
                "like_count": 0,
                "quote_count": 0,
                "reply_count": 0,
                "retweet_count": 0
            },
            "text": "@EU_Commission Fraser Cummings @UHSFT: data suggest that there is 40% use of biosimilar infliximab in the UK"
        },
        {
            "conversation_id": "744837968456626176",
            "created_at": "2016-06-20T10:23:04.000Z",
            "id": "744837968456626176",
            "lang": "en",
            "public_metrics": {
                "like_count": 0,
                "quote_count": 0,
                "reply_count": 0,
                "retweet_count": 0
            },
            "text": "@EU_Commission Fraser Cummings @UHSFT: we have data from EMA on difference between biosimilar and originator, but not between biosimilars"
        },
        {
            "conversation_id": "744837284382412800",
            "created_at": "2016-06-20T10:20:21.000Z",
            "id": "744837284382412800",
            "lang": "en",
            "public_metrics": {
                "like_count": 0,
                "quote_count": 0,
                "reply_count": 0,
                "retweet_count": 0
            },
            "text": "@EU_Commission Fraser Cummings @UHSFT: there are challenges to using subcutaneous biosimilars"
        },
        {
            "conversation_id": "744837093428330497",
            "created_at": "2016-06-20T10:19:36.000Z",
            "id": "744837093428330497",
            "lang": "en",
            "public_metrics": {
                "like_count": 0,
                "quote_count": 0,
                "reply_count": 0,
                "retweet_count": 0
            },
            "text": "@EU_Commission Fraser Cummings @UHSFT: we need to develop therapeutic knowledge to really know how/when to use biologics/biosimilars"
        },
        {
            "conversation_id": "744836714120814592",
            "created_at": "2016-06-20T10:18:05.000Z",
            "id": "744836714120814592",
            "lang": "en",
            "public_metrics": {
                "like_count": 0,
                "quote_count": 0,
                "reply_count": 0,
                "retweet_count": 0
            },
            "text": "@EU_Commission\nALERT!\nNorthern elites of Nigeria with #UK #US #UN plans to kill Nnamdi Kanu in army coup to replace Buhari &amp; stop #Biafra."
        },
        {
            "conversation_id": "744836658764210177",
            "created_at": "2016-06-20T10:17:52.000Z",
            "id": "744836658764210177",
            "lang": "en",
            "public_metrics": {
                "like_count": 0,
                "quote_count": 0,
                "reply_count": 0,
                "retweet_count": 1
            },
            "text": "@EU_Commission Fraser Cummings @UHSFT: our experience of outcomes of switching patient to biosimilar infliximab are same as with biologic"
        },
        {
            "conversation_id": "744833605323493377",
            "created_at": "2016-06-20T10:05:44.000Z",
            "id": "744833605323493377",
            "lang": "en",
            "public_metrics": {
                "like_count": 0,
                "quote_count": 0,
                "reply_count": 0,
                "retweet_count": 0
            },
            "text": "@EU_Commission Fraser Cummings @UHSFT: the most important issue in switching patients to biosimilars is incentivisation"
        },
        {
            "conversation_id": "744833587611078657",
            "created_at": "2016-06-20T10:05:40.000Z",
            "id": "744833587611078657",
            "lang": "en",
            "public_metrics": {
                "like_count": 0,
                "quote_count": 0,
                "reply_count": 0,
                "retweet_count": 0
            },
            "text": "@EU_Commission \rALERT!\rNorthern elites of Nigeria with #UK #US #UN plans to kill Nnamdi Kanu in army coup to replace Buhari &amp;amp; stop #Bi"
        },
        {
            "conversation_id": "744833181291995137",
            "created_at": "2016-06-20T10:04:03.000Z",
            "id": "744833181291995137",
            "lang": "en",
            "public_metrics": {
                "like_count": 0,
                "quote_count": 0,
                "reply_count": 0,
                "retweet_count": 0
            },
            "text": "@EU_Commission Fraser Cummings @UHSFT: rising expenditure on Remicade made us consider biosimilars in Sept. 2014"
        }
    ],
    "meta": {
        "newest_id": "745454184342818816",
        "next_token": "1jzu9lk96gu5npw2xzn02jghpisw1gqk4icbamznhhtp",
        "oldest_id": "744833181291995137",
        "result_count": 97
    }
}